Additional targeted strategies, including combinations of VEGF/tyrosine kinase inhibition and PD-1 blockade, have shown signals of activity in small penile subsets within rare cancer basket trials, but responses have so far been transient [246,252,253]. This evidence concerns the gene VEGFA and cancer.